Activation of phospholipase D in normodense human eosinophils

Biochemical and Biophysical Research Communications
M MinnicozziR W Egan

Abstract

Normodense human eosinophils have been labeled in 1-0-alkyl-phosphatidylcholine (alkyl-PC) with 32P by incubating isolated cells with alkyl-[32P]lysoPC. Stimulation of these 32P-labeled cells with C5a, A23187 or PMA in the presence of 0.5% ethanol resulted in time- and dose-dependent formation of alkyl-[32P]phosphatidic acid (alkyl-[32P]PA) and alkyl-[32P]phosphatidylethanol (alkyl-[32P]PEt). Because cellular ATP does not contain 32P, alkyl-[32P]PA must have been formed by the hydrolytic action of phospholipase D (PLD) and not by the combined actions of phospholipase C and DG kinase. Regardless of the stimulating agent, alkyl-[32P]PEt formation paralleled that of alkyl-[32P]PA, suggesting that alkyl-PEt was the result of a PLD-catalyzed transphosphatidylation reaction between alkyl-PC and ethanol. These data provide the first definitive proof of receptor- and nonreceptor-mediated activation of PLD in normodense eosinophils derived from human blood.

References

May 1, 1976·The Journal of Clinical Investigation·L A KaterK F Austen
Mar 25, 1975·Biochimica Et Biophysica Acta·R H Michell
Jul 31, 1989·Biochemical and Biophysical Research Communications·S C KinskyS H Benedict
Jul 18, 1986·Science·Y Nishizuka
Jan 1, 1987·Annual Review of Biochemistry·M J Berridge
Jul 1, 1987·Allergy·A J Wardlaw, A B Kay
Jan 1, 1986·Advances in Immunology·G J Gleich, C R Adolphson
Sep 11, 1986·Nature·W H MoolenaarS W de Laat
Jan 1, 1984·Annual Review of Immunology·R Snyderman, M C Pike
Aug 1, 1959·Canadian Journal of Biochemistry and Physiology·E G BLIGH, W J DYER

❮ Previous
Next ❯

Citations

Jul 1, 1994·Journal of Cellular Biochemistry·L P WennogleS I Hu
May 24, 1996·Chemistry and Physics of Lipids·S Cockcroft
Jul 30, 1999·Biochimica Et Biophysica Acta·K E MeierK M Ella
Aug 1, 1996·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·T van der Bruggen, L Koenderman
Sep 1, 1993·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·J Shute
Sep 26, 2000·Pulmonary Pharmacology & Therapeutics·M A GiembyczM A Lindsay
Jan 1, 1997·Memórias do Instituto Oswaldo Cruz·M A Lindsay, M A Giembycz
Apr 14, 2007·Journal of Leukocyte Biology·Julian Gomez-CambroneroKatie Knapek

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.